The l-arginine/nitric oxide pathway contributes to the acute release of tissue plasminogen activator in vivo in man

This publication has 51 references indexed in Scilit:

• Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris
  New England Journal of Medicine, 1995
• Prospective study of endogenous tissue plasminogen activator and risk of stroke
  The Lancet, 1994
• Endogenous tissue-type plasminogen activator and risk of myocardial infarction
  The Lancet, 1993
• Serial angiographic assessment of coronary artery obstruction and collateral flow in acute myocardial infarction. Report from the second Mount Sinai-New York University Reperfusion Trial.
  Circulation, 1989
• Tissue plasminogen activator: Toronto (TPAT) placebo-controlled randomized trial in acute myocardial infarction
  Journal of the American College of Cardiology, 1989
• Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial Infarction
  New England Journal of Medicine, 1985
• Prevention of coronary thrombosis with subthrombolytic doses of tissue-type plasminogen activator.
  Circulation, 1985
• The level of extrinsic plasminogen activator (t-PA) during clotting as a determinant of the rate of fibrinolysis; inefficiency of activators added afterwards
  Thrombosis Research, 1984
• Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial Infarction
  New England Journal of Medicine, 1980
• Factor VIII and Fibrinolytic Response to Deamino‐8‐d‐Argenine Vasopressin in Normal Subjects and Dissociate Response in Some Patients with Haemophilia and von Willebrand's Disease
  British Journal of Haematology, 1980